LifeMD (LFMD) Cost of Revenue (2012 - 2025)

LifeMD (LFMD) has reported Cost of Revenue for 14 consecutive years, with $4.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue fell 37.78% year-over-year to $4.2 million; the trailing twelve-month figure through Dec 2025 stood at $27.7 million (up 29.26% YoY), and the FY2025 full-year result was $27.7 million, up 29.26% from the prior year.
• Cost of Revenue slipped to $4.2 million in Q4 2025 per LFMD's latest filing, from $7.4 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $8.6 million in Q1 2025 and bottomed at $3.2 million in Q1 2021.
• Historically, Cost of Revenue has averaged $5.2 million across 5 years, with a median of $4.9 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Cost of Revenue soared 204.16% in 2021, then slumped 37.78% in 2025.
• Over 5 years, Cost of Revenue stood at $5.6 million in 2021, then fell by 26.94% to $4.1 million in 2022, then surged by 31.66% to $5.4 million in 2023, then gained by 27.01% to $6.8 million in 2024, then plunged by 37.78% to $4.2 million in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $4.2 million, $7.4 million, and $7.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.